| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACTN4
|
actinin, alpha 4
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ANXA2
|
annexin A2
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AR
|
androgen receptor
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ATF1
|
activating transcription factor 1
|
|
ATF5
|
activating transcription factor 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
AURKA
|
aurora kinase A
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BECN1
|
beclin 1, autophagy related
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BHLHE41
|
basic helix-loop-helix family, member e41
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CA9
|
carbonic anhydrase IX
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CANX
|
calnexin
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA1
|
cyclin A1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRNA9
|
cholinergic receptor, nicotinic, alpha 9 (neuronal)
|
|
CLDN1
|
claudin 1
|
|
CLDN6
|
claudin 6
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPD
|
carboxypeptidase D
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CSN3
|
casein kappa
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
E2F1
|
E2F transcription factor 1
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EMP1
|
epithelial membrane protein 1
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAS
|
Fas cell surface death receptor
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FHL2
|
four and a half LIM domains 2
|
|
FOXA1
|
forkhead box A1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
GALNT14
|
polypeptide N-acetylgalactosaminyltransferase 14
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA3
|
GATA binding protein 3
|
|
GH1
|
growth hormone 1
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HEPACAM
|
hepatic and glial cell adhesion molecule
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IL1B
|
interleukin 1, beta
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
JUN
|
jun proto-oncogene
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MFN2
|
mitofusin 2
|
|
MIR145
|
microRNA 145
|
|
MIR155
|
microRNA 155
|
|
MIR197
|
microRNA 197
|
|
MIR206
|
microRNA 206
|
|
MIR21
|
microRNA 21
|
|
MIR27A
|
microRNA 27a
|
|
MIR3134
|
microRNA 3134
|
|
MIR375
|
microRNA 375
|
|
MIR451A
|
microRNA 451a
|
|
MIR888
|
microRNA 888
|
|
MIR93
|
microRNA 93
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRC2
|
mannose receptor, C type 2
|
|
MSLN
|
mesothelin
|
|
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLK
|
nemo-like kinase
|
|
NMI
|
N-myc (and STAT) interactor
|
|
NOA1
|
nitric oxide associated 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRG1
|
neuregulin 1
|
|
OSM
|
oncostatin M
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PAPSS1
|
3'-phosphoadenosine 5'-phosphosulfate synthase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDZD2
|
PDZ domain containing 2
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEPD
|
peptidase D
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLAC1
|
placenta-specific 1
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLK1
|
polo-like kinase 1
|
|
PML
|
promyelocytic leukemia
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
PODXL
|
podocalyxin-like
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPP1R13B
|
protein phosphatase 1, regulatory subunit 13B
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKD1
|
protein kinase D1
|
|
PRNP
|
prion protein
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PVRL4
|
poliovirus receptor-related 4
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RARS
|
arginyl-tRNA synthetase
|
|
RBBP4
|
retinoblastoma binding protein 4
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM14
|
RNA binding motif protein 14
|
|
RBM5
|
RNA binding motif protein 5
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RPL19
|
ribosomal protein L19
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RTKN
|
rhotekin
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
SAV1
|
salvador family WW domain containing protein 1
|
|
SDC4
|
syndecan 4
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIM2
|
single-minded family bHLH transcription factor 2
|
|
SIRT6
|
sirtuin 6
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SLC39A4
|
solute carrier family 39 (zinc transporter), member 4
|
|
SLC39A7
|
solute carrier family 39 (zinc transporter), member 7
|
|
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOCS7
|
suppressor of cytokine signaling 7
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
ST18
|
suppression of tumorigenicity 18, zinc finger
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STK11
|
serine/threonine kinase 11
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFAP4
|
transcription factor AP-4 (activating enhancer binding protein 4)
|
|
TFF1
|
trefoil factor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TP53INP1
|
tumor protein p53 inducible nuclear protein 1
|
|
TP73
|
tumor protein p73
|
|
TRIM28
|
tripartite motif containing 28
|
|
TXN
|
thioredoxin
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIM
|
vimentin
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
VTRNA2-1
|
vault RNA 2-1
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
|
WT1
|
Wilms tumor 1
|
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1
|
|
YPEL3
|
yippee-like 3 (Drosophila)
|
|
ZBTB10
|
zinc finger and BTB domain containing 10
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZNF703
|
zinc finger protein 703
|